Class II · Moderate risk
Fungo Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II drug recalls - moderate risk
Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.
14,543 recalls, newest first.
Class II · Moderate risk
Fungo Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Flare Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Fire Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Edema Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Dragon Pain Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Detoxin-S
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Detoxin Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
DeTensin Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Dermatoxin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Dermamycin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
De-Fibroidin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Cellulite Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Blood Clot Purger
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Bleeding Stop
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Asthma Chest Rub
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Asma Stopper
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Age Stop Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Age Back
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Acne Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Acne Cystic
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Acupuncture
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Dermatone (avobenzone, homosalate, octisalate, and octocrylene)
Microbial contamination of non-sterile products: positive test for yeast and bacteria.
Class II · Moderate risk
Dermatone (avobenzone, homosalate, octisalate, and octocrylene)
Microbial contamination of non-sterile products: positive test for yeast and bacteria.
Class II · Moderate risk
Draximage Dtpa
Failed Stability Specifications